{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:26:18Z","timestamp":1782221178853,"version":"3.54.5"},"reference-count":60,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceutical Company Limited","doi-asserted-by":"publisher","award":["Takeda Pharmaceutical Company Limited"],"award-info":[{"award-number":["Takeda Pharmaceutical Company Limited"]}],"id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Acceleration Program for Intractable Diseases Research utilizing disease-specific iPSCs","award":["19bm0804005h0003"],"award-info":[{"award-number":["19bm0804005h0003"]}]},{"name":"Acceleration Program for Intractable Diseases Research utilizing disease-specific iPSCs","award":["20bm0804005h0004"],"award-info":[{"award-number":["20bm0804005h0004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Ca2+ overload is one of the factors leading to Duchenne muscular dystrophy (DMD) pathogenesis. However, the molecular targets of dystrophin deficiency-dependent Ca2+ overload and the correlation between Ca2+ overload and contractile DMD phenotypes in in vitro human models remain largely elusive. In this study, we utilized DMD patient-derived induced pluripotent stem cells (iPSCs) to differentiate myotubes using doxycycline-inducible MyoD overexpression, and searched for a target molecule that mediates dystrophin deficiency-dependent Ca2+ overload using commercially available chemicals and siRNAs. We found that several store-operated Ca2+ channel (SOC) inhibitors effectively prevented Ca2+ overload and identified that STIM1\u2013Orai1 is a molecular target of SOCs. These findings were further confirmed by demonstrating that STIM1\u2013Orai1 inhibitors, CM4620, AnCoA4, and GSK797A, prevented Ca2+ overload in dystrophic myotubes. Finally, we evaluated CM4620, AnCoA4, and GSK7975A activities using a previously reported model recapitulating a muscle fatigue-like decline in contractile performance in DMD. All three chemicals ameliorated the decline in contractile performance, indicating that modulating STIM1\u2013Orai1-mediated Ca2+ overload is effective in rescuing contractile phenotypes. In conclusion, SOCs are major contributors to dystrophin deficiency-dependent Ca2+ overload through STIM1\u2013Orai1 as molecular mediators. Modulating STIM1\u2013Orai1 activity was effective in ameliorating the decline in contractile performance in DMD.<\/jats:p>","DOI":"10.3390\/biomedicines9111589","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T11:47:38Z","timestamp":1635767258000},"page":"1589","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Orai1\u2013STIM1 Regulates Increased Ca2+ Mobilization, Leading to Contractile Duchenne Muscular Dystrophy Phenotypes in Patient-Derived Induced Pluripotent Stem Cells"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6577-4774","authenticated-orcid":false,"given":"Tomoya","family":"Uchimura","sequence":"first","affiliation":[{"name":"Center for iPSC Cell Research and Application (CiRA), Kyoto University, 53 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan"},{"name":"Takeda-CiRA Joint Program, Fujisawa 251-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-9366","authenticated-orcid":false,"given":"Hidetoshi","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Center for iPSC Cell Research and Application (CiRA), Kyoto University, 53 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan"},{"name":"Takeda-CiRA Joint Program, Fujisawa 251-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrg3460","article-title":"Therapy for Duchenne muscular dystrophy: Renewed optimism from genetic approaches","volume":"14","author":"Fairclough","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Manzur, A.Y., Kuntzer, T., Pike, M., and Swan, A. (2008). Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst. Rev., CD003725.","DOI":"10.1002\/14651858.CD003725.pub3"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Matthews, E., Brassington, R., Kuntzer, T., Jichi, F., and Manzur, A.Y. (2016). Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev., CD003725.","DOI":"10.1002\/14651858.CD003725.pub4"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/hum.2018.012","article-title":"Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients","volume":"29","author":"Duan","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nmd.2020.05.002","article-title":"Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy","volume":"30","author":"Wagner","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41434-020-0156-6","article-title":"Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy","volume":"27","author":"Dzierlega","year":"2020","journal-title":"Gene Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1440-1681.2004.04032.x","article-title":"Skeletal muscle function: Role of ionic changes in fatigue, damage and disease","volume":"31","author":"Allen","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archneur.1961.00450110050006","article-title":"Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases","volume":"4","author":"Okinaka","year":"1961","journal-title":"Arch. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<106::AID-MUS14>3.0.CO;2-D","article-title":"Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition","volume":"23","author":"Badalamente","year":"2000","journal-title":"Muscle Nerve"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.pmrj.2009.04.010","article-title":"Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention","volume":"1","author":"Evans","year":"2009","journal-title":"PM&R"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1093\/hmg\/ddq339","article-title":"Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy","volume":"19","author":"Menazza","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1073\/pnas.0906591106","article-title":"Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism","volume":"106","author":"Millay","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"165674","DOI":"10.1016\/j.bbadis.2020.165674","article-title":"Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition","volume":"1866","author":"Dubinin","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.1096\/fj.201802298R","article-title":"Mitochondrial dysfunction causes Ca2+ overload and ECM degradation-mediated muscle damage in C. elegans","volume":"33","author":"Sudevan","year":"2019","journal-title":"FASEB J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jcsm.12405","article-title":"Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2O2 emission during impaired oxidative phosphorylation","volume":"10","author":"Hughes","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrd3577","article-title":"Induced pluripotent stem cells\u2014Opportunities for disease modelling and drug discovery","volume":"10","author":"Grskovic","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"647010","DOI":"10.3389\/fphys.2021.647010","article-title":"Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies","volume":"12","author":"Mareedu","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12831","DOI":"10.1038\/srep12831","article-title":"Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells","volume":"5","author":"Shoji","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fphys.2018.00257","article-title":"The Complex Role of Store Operated Calcium Entry Pathways and Related Proteins in the Function of Cardiac, Skeletal and Vascular Smooth Muscle Cells","volume":"9","author":"Ribas","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00020.2014","article-title":"Store-Operated Calcium Channels","volume":"95","author":"Prakriya","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ceca.2018.10.004","article-title":"Role of STIM1\/ORAI1-mediated store-operated Ca(2+) entry in skeletal muscle physiology and disease","volume":"76","author":"Michelucci","year":"2018","journal-title":"Cell Calcium"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/ncomms3805","article-title":"Orai1-dependent calcium entry promotes skeletal muscle growth and limits fatigue","volume":"4","author":"Carrell","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"14286","DOI":"10.1038\/s41598-017-14134-0","article-title":"Exercise-dependent formation of new junctions that promote STIM1-Orai1 assembly in skeletal muscle","volume":"7","author":"Boncompagni","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhao, X., Moloughney, J.G., Zhang, S., Komazaki, S., and Weisleder, N. (2012). Orai1 mediates exacerbated Ca2+ entry in dystrophic skeletal muscle. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049862"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2044-5040-1-16","article-title":"STIM1 as a key regulator for Ca2+ homeostasis in skeletal-muscle development and function","volume":"1","author":"Kiviluoto","year":"2011","journal-title":"Skelet. Muscle"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbamcr.2017.02.003","article-title":"TRPC1 and TRPC4 channels functionally interact with STIM1L to promote myogenesis and maintain fast repetitive Ca2+ release in human myotubes","volume":"1864","author":"Antigny","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1093\/hmg\/ddu079","article-title":"Enhanced Ca2+ influx from STIM1-Orai1 induces muscle pathology in mouse models of muscular dystrophy","volume":"23","author":"Goonasekera","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","article-title":"Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9","volume":"4","author":"Li","year":"2015","journal-title":"Stem Cell Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.scr.2017.10.023","article-title":"A human iPS cell myogenic differentiation system permitting high-throughput drug screening","volume":"25","author":"Uchimura","year":"2017","journal-title":"Stem Cell Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tanaka, A., Woltjen, K., Miyake, K., Hotta, A., Ikeya, M., Yamamoto, T., Nishino, T., Shoji, E., Sehara-Fujisawa, A., and Manabe, Y. (2013). Efficient and reproducible myogenic differentiation from human iPS cells: Prospects for modeling Miyoshi Myopathy in vitro. PLoS ONE, 8.","DOI":"10.1371\/annotation\/63972dc9-3a31-43d0-ad52-bc46fd948c03"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ymeth.2015.12.012","article-title":"Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives","volume":"101","author":"Kim","year":"2016","journal-title":"Methods"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1083\/jcb.201012157","article-title":"STIM1L is a new actin-binding splice variant involved in fast repetitive Ca2+ release","volume":"194","author":"Darbellay","year":"2011","journal-title":"J. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e47576","DOI":"10.7554\/eLife.47576","article-title":"Transverse tubule remodeling enhances Orai1-dependent Ca2+ entry in skeletal muscle","volume":"8","author":"Michelucci","year":"2019","journal-title":"eLife"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e202012617","DOI":"10.1085\/jgp.202012617","article-title":"Pre-assembled Ca2+ entry units and constitutively active Ca2+ entry in skeletal muscle of calsequestrin-1 knockout mice","volume":"152","author":"Michelucci","year":"2020","journal-title":"J. Gen. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100298","DOI":"10.1016\/j.xcrm.2021.100298","article-title":"A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs","volume":"2","author":"Uchimura","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1469-7793.2001.0185b.x","article-title":"Depletion of Ca2+ in the sarcoplasmic reticulum stimulates Ca2+ entry into mouse skeletal muscle fibres","volume":"533","author":"Kurebayashi","year":"2001","journal-title":"J. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bpj.2016.11.013","article-title":"GsMTx4: Mechanism of Inhibiting Mechanosensitive Ion Channels","volume":"112","author":"Gnanasambandam","year":"2017","journal-title":"Biophys. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"32680","DOI":"10.1074\/jbc.274.46.32680","article-title":"Ruthenium red modifies the cardiac and skeletal muscle Ca2+ release channels (ryanodine receptors) by multiple mechanisms","volume":"274","author":"Xu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1096\/fj.02-0037rev","article-title":"2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release","volume":"16","author":"Bootman","year":"2002","journal-title":"FASEB J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ceca.2015.07.001","article-title":"The STIM1-ORAI1 microdomain","volume":"58","author":"Hogan","year":"2015","journal-title":"Cell Calcium"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.chembiol.2014.08.016","article-title":"Identification of Orai1 channel inhibitors by using minimal functional domains to screen small molecule microarrays","volume":"21","author":"Sadaghiani","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1113\/JP277856","article-title":"The Orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis","volume":"597","author":"Waldron","year":"2019","journal-title":"J. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"a006023","DOI":"10.1101\/cshperspect.a006023","article-title":"Signaling in muscle contraction","volume":"7","author":"Kuo","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1570-9639(02)00442-9","article-title":"New aspects of calcium signaling in skeletal muscle cells: Implications in Duchenne muscular dystrophy","volume":"1600","author":"Gailly","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1469-7793.1999.859ab.x","article-title":"Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers","volume":"515","author":"Tutdibi","year":"1999","journal-title":"J. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm.1916","article-title":"Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle","volume":"15","author":"Bellinger","year":"2009","journal-title":"Nat. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00401-020-02150-w","article-title":"Intracellular calcium leak as a therapeutic target for RYR1-related myopathies","volume":"139","author":"Kushnir","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10479","DOI":"10.1073\/pnas.1300410110","article-title":"Mitochondrial calcium uptake","volume":"110","author":"Williams","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Dubinin, M.V., Talanov, E.Y., Tenkov, K.S., Starinets, V.S., Belosludtseva, N.V., and Belosludtsev, K.N. (2020). The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228763"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/bj3000665","article-title":"Ionomycin enhances Ca2+ influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane","volume":"300","author":"Morgan","year":"1994","journal-title":"Biochem. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/apha.12830","article-title":"Electrical pulse stimulation of cultured skeletal muscle cells as a model for in vitro exercise\u2014Possibilities and limitations","volume":"220","author":"Thoresen","year":"2017","journal-title":"Acta Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1085\/jgp.201110738","article-title":"Sarcoplasmic reticulum Ca2+ permeation explored from the lumen side in mdx muscle fibers under voltage control","volume":"139","author":"Robin","year":"2012","journal-title":"J. Gen. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.1038\/emm.2017.208","article-title":"A focus on extracellular Ca2+ entry into skeletal muscle","volume":"49","author":"Cho","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"C881","DOI":"10.1152\/ajpcell.00182.2012","article-title":"Involvement of TRPV2 and SOCE in calcium influx disorder in DMD primary human myotubes with a specific contribution of alpha1-syntrophin and PLC\/PKC in SOCE regulation","volume":"304","author":"Harisseh","year":"2013","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"600758","DOI":"10.3389\/fncel.2020.600758","article-title":"Store-Operated Calcium Channels in Physiological and Pathological States of the Nervous System","volume":"14","author":"Zhang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1124\/mol.109.055624","article-title":"Pharmacology of vanilloid transient receptor potential cation channels","volume":"75","author":"Vriens","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0014-5793(00)02268-7","article-title":"Use of ruthenium red as an inhibitor of mitochondrial Ca2+ uptake in single rat cardiomyocytes","volume":"486","author":"Griffiths","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_59","first-page":"1568","article-title":"STIM1L traps and gates Orai1 channels without remodeling the cortical ER","volume":"128","author":"Bulla","year":"2015","journal-title":"J. Cell Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbrc.2012.10.034","article-title":"Different binding property of STIM1 and its novel splice variant STIM1L to Orai1, TRPC3, and TRPC6 channels","volume":"428","author":"Horinouchi","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/11\/1589\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:24:05Z","timestamp":1760167445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/11\/1589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,31]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["biomedicines9111589"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9111589","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,31]]}}}